Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Co-diagnostics, Inc. (CODX) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Co-diagnostics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1692415.
Total stock buying since 2018: $11,819,007.
Total stock sales since 2018: $6,159,177.
Total stock option exercises since 2018: $869,668.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 3,000 | $5,697 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 181,380 | $1,699,144 | 158,334 | $361,168 |
| 2020 | 0 | $0 | 350,874 | $4,460,033 | 377,000 | $508,500 |
| 2018 | 5,205 | $11,813,310 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-03 | 3,000 | $5,697 | 0 | $0 | 0 | $0 |
| 2021-09 | 0 | $0 | 2,000 | $20,910 | 0 | $0 |
| 2021-05 | 0 | $0 | 108,334 | $924,197 | 108,334 | $229,668 |
| 2021-01 | 0 | $0 | 71,046 | $754,037 | 50,000 | $131,500 |
| 2020-12 | 0 | $0 | 27,000 | $273,200 | 0 | $0 |
| 2020-11 | 0 | $0 | 223,874 | $2,357,459 | 277,000 | $275,000 |
| 2020-05 | 0 | $0 | 100,000 | $1,829,374 | 100,000 | $233,500 |
| 2018-05 | 1,805 | $3,330 | 0 | $0 | 0 | $0 |
| 2018-04 | 3,400 | $11,809,980 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-20 | Brown Brian Lee (Chief Financial Officer) | Buy | 3,000 | 1.90 | 5,697 |
| 2021-09-08 | Durenard Eugene | Sale | 2,000 | 10.46 | 20,910 |
| 2021-05-19 | Benson Reed L (General Counsel) | Sale | 108,334 | 8.53 | 924,197 |
| 2021-05-19 | Benson Reed L (General Counsel) | Option Ex | 108,334 | 2.12 | 229,668 |
| 2021-01-15 | Egan Dwight H (Chief Executive Officer) | Sale | 38,046 | 11.00 | 418,506 |
| 2021-01-15 | Egan Dwight H (Chief Executive Officer) | Option Ex | 50,000 | 2.63 | 131,500 |
| 2021-01-14 | Serbin Richard S | Sale | 10,000 | 10.29 | 102,899 |
| 2021-01-13 | Durenard Eugene | Sale | 10,500 | 10.09 | 105,945 |
| 2021-01-13 | Nelson James B | Sale | 12,500 | 10.13 | 126,687 |
| 2020-12-14 | Serbin Richard S | Sale | 17,000 | 10.10 | 171,700 |
| 2020-12-10 | Durenard Eugene | Sale | 10,000 | 10.15 | 101,500 |
| 2020-11-25 | Benson Reed L (CFO and Secretary) | Sale | 89,524 | 10.50 | 940,002 |
| 2020-11-25 | Benson Reed L (CFO and Secretary) | Option Ex | 100,000 | 1.10 | 110,000 |
| 2020-11-24 | Egan Dwight H (Chief Executive Officer) | Sale | 44,764 | 10.51 | 470,469 |
| 2020-11-24 | Egan Dwight H (Chief Executive Officer) | Option Ex | 50,000 | 1.10 | 55,000 |
| 2020-11-23 | Durenard Eugene | Option Ex | 10,000 | .00 | 0 |
| 2020-11-23 | Egan Dwight H (Chief Executive Officer) | Sale | 71,569 | 10.44 | 747,180 |
| 2020-11-23 | Egan Dwight H (Chief Executive Officer) | Option Ex | 80,000 | 1.10 | 88,000 |
| 2020-11-23 | Serbin Richard S | Option Ex | 17,000 | .00 | 0 |
| 2020-11-20 | Egan Dwight H (Chief Executive Officer) | Sale | 18,017 | 11.09 | 199,808 |
| 2020-11-20 | Egan Dwight H (Chief Executive Officer) | Option Ex | 20,000 | 1.10 | 22,000 |
| 2020-05-28 | Serbin Richard S | Sale | 25,000 | 18.02 | 450,375 |
| 2020-05-28 | Serbin Richard S | Option Ex | 25,000 | 3.96 | 99,000 |
| 2020-05-26 | Durenard Eugene | Sale | 25,000 | 18.26 | 456,500 |
| 2020-05-20 | Durenard Eugene | Sale | 25,000 | 18.40 | 459,999 |
| 2020-05-20 | Durenard Eugene | Option Ex | 50,000 | 2.33 | 116,750 |
| 2020-05-19 | Serbin Richard S | Sale | 25,000 | 18.50 | 462,500 |
| 2020-05-19 | Serbin Richard S | Option Ex | 25,000 | .71 | 17,750 |
| 2018-05-11 | Satterfield Brent (Chief Science Officer) | Buy | 1,305 | 1.82 | 2,375 |
| 2018-05-03 | Satterfield Brent (Chief Science Officer) | Buy | 500 | 1.91 | 955 |
| 2018-04-23 | Satterfield Brent (Chief Science Officer) | Buy | 500 | 2.02 | 1,010 |
| 2018-04-16 | Satterfield Brent (Chief Science Officer) | Buy | 500 | 1.94 | 970 |
| 2018-04-09 | Satterfield Brent (Chief Science Officer) | Buy | 2,400 | 4,920.00 | 11,808,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CODX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Co-diagnostics, Inc. (symbol CODX, CIK number 1692415) see the Securities and Exchange Commission (SEC) website.